HDAC9 and neoplasm: In breast cancer, loss of Akkermansia muciniphila-derived butyrate, a histone deacetylase (HDAC) inhibitor that suppresses Wnt/β-catenin signaling via LRP5 destabilization, promotes tumor stemness and accelerates tumor progression 25.